Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Treating ADHD is straightforward with stimulants, often giving patients life-changing relief. But with comorbid conditions, ...

The company is seeking approval from the US regulator for Vraylar (cariprazine) as an add-on to conventional ... not respond to typical antidepressant medications. The dopamine D2/D3 receptor ...

Clinicians and researchers have long known that a prime contributor to depression is the inability to process negative emotions in constructive or adaptive ways. Medication can relieve some of the ...

A study of older adults showed that 6% had depression, with higher prevalences in certain groups, including women, those who ...

Even individuals whose symptoms do not yet meet the criteria for clinical depression benefit from therapeutic interventions. This conclusion comes from a new meta-study by researchers who analyzed ...

In the UK, primary care doctors can already recommend exercise, psychotherapy, or drug treatment for patients with mild to moderate depression under NICE guidance, but exercise is rarely ...

While antidepressant drugs are widely prescribed to treat depression and anxiety disorders, only one-third of drug-treated patients exhibit a beneficial therapeutic response. [1] Response and ...

Adults with attention-deficit/hyperactivity disorder, or ADHD, who use an extended-release medication are more likely to ...